190 related articles for article (PubMed ID: 21530962)
1. Prevention of ovarian hyperstimulation syndrome.
Wiwanitkit V
Fertil Steril; 2011 Jun; 95(8):e65; author reply e66. PubMed ID: 21530962
[No Abstract] [Full Text] [Related]
2. Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
Spitzer D; Wogatzky J; Murtinger M; Zech MH; Haidbauer R; Zech NH
Fertil Steril; 2011 Jun; 95(8):2742-4.e1. PubMed ID: 21411081
[TBL] [Abstract][Full Text] [Related]
3. The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.
Beltrame AL; Serafini P; Motta EL; Soares Júnior JM; Baracat EC
Gynecol Endocrinol; 2013 Mar; 29(3):201-4. PubMed ID: 23167783
[TBL] [Abstract][Full Text] [Related]
4. Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
Kasum M; Vrčić H; Stanić P; Ježek D; Orešković S; Beketić-Orešković L; Pekez M
Gynecol Endocrinol; 2014; 30(12):845-9. PubMed ID: 25093428
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
[No Abstract] [Full Text] [Related]
6. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
7. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome: a preventable syndrome?
Rosenwaks Z; Benadiva C
Semin Reprod Med; 2010 Nov; 28(6):437-9. PubMed ID: 21082500
[No Abstract] [Full Text] [Related]
9. [Use of cabergoline for prevention of ovarian hyperstimulation syndrome in assisted reproductive technologies].
Kozovski G; Angelova M; Kacarova P
Akush Ginekol (Sofiia); 2014; 53(5):34-5. PubMed ID: 25558669
[TBL] [Abstract][Full Text] [Related]
10. Can we eliminate severe ovarian hyperstimulation syndrome? Comment 2.
De Neubourg D; Gerris J
Hum Reprod; 2005 Aug; 20(8):2369; author reply 2369-70. PubMed ID: 16024547
[No Abstract] [Full Text] [Related]
11. Can we eliminate severe ovarian hyperstimulation syndrome? Not completely.
Buckett W; Chian RC; Tan SL
Hum Reprod; 2005 Aug; 20(8):2367; author reply 2367-8. PubMed ID: 16024544
[No Abstract] [Full Text] [Related]
12. Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?
Manno M; Tomei F; Marchesan E; Adamo V
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):127-8. PubMed ID: 16154051
[No Abstract] [Full Text] [Related]
13. Etiology of OHSS and use of dopamine agonists.
Soares SR
Fertil Steril; 2012 Mar; 97(3):517-22. PubMed ID: 22265002
[TBL] [Abstract][Full Text] [Related]
14. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864
[TBL] [Abstract][Full Text] [Related]
15. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
16. Can we eliminate severe ovarian hyperstimulation syndrome? Comment I.
Manno M
Hum Reprod; 2005 Aug; 20(8):2368-9; author reply 2369-70. PubMed ID: 16024545
[No Abstract] [Full Text] [Related]
17. Physiology and pathology of ovarian hyperstimulation syndrome.
Gómez R; Soares SR; Busso C; Garcia-Velasco JA; Simón C; Pellicer A
Semin Reprod Med; 2010 Nov; 28(6):448-57. PubMed ID: 21082502
[TBL] [Abstract][Full Text] [Related]
18. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
Antoine JM; Verstraete L
Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
[No Abstract] [Full Text] [Related]
19. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
Zarek SM; Muasher SJ
Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
[TBL] [Abstract][Full Text] [Related]
20. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis.
Baumgarten M; Polanski L; Campbell B; Raine-Fenning N
Hum Fertil (Camb); 2013 Sep; 16(3):168-74. PubMed ID: 24047196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
